SynthesisNeurogastroenterology and motility2026
A Genome-Wide Meta-Analysis of Functional Dyspepsia in 1,168,899 Individuals Implicates Immune Pathways in Disease Susceptibility.
Synthesis in Neurogastroenterology and motility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
backgroundFunctional dyspepsia (FD) affects over 7% of the global population, impairing quality of life and driving significant healthcare burden. Although genetic contributions to FD pathophysiology have been suspected, large, well-powered genetic studies remain limited. We aimed to identify FD genetic risk factors and implicated biological pathways.
methodsWe performed a FD genome-wide association study in 1,168,899 European individuals, including 29,584 FD cases from five large biobanks. We dissected the genetic architecture of FD and its overlap with gastrointestinal and psychiatric disorders and conducted comprehensive gene-prioritization, regulatory, and cell-type enrichment analyzes to identify pathophysiological mechanisms and actionable targets. KEY
resultsWe show FD is a complex, highly polygenic trait with a significant genetic component (3.63% heritability) but lower than similar gastrointestinal disorders like irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). Mendelian randomization revealed causal effects of depression and anxiety on FD risk. We observed substantial local genetic correlations with IBS and GERD, including shared genome-wide significant signals at the human leukocyte antigen region, supporting immune-mediated mechanisms. Gene-prioritization analyzes converged on DEAH-Box Helicase 36 (DHX36), involved in immune responses to microbial infections. Integrative expression-quantitative trait loci and colocalization analyzes indicated that higher genetic risk of FD is causally associated with a reduced DHX36 expression in gastrointestinal tissues, potentially triggering increased proinflammatory cytokine production. CONCLUSIONS & INFERENCES: This study implicates immune-driven pathways in FD susceptibility, adds insights into the pathophysiological mechanisms of the disease, and reveals DHX36 as a candidate target for future investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.